CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: doramapimod
Accession: CHEBI:40953
browse the term
Definition: A member of the class of pyrazoles that is an immunomodulator used for treatment of rheumatoid arthritis, Crohn's disease and psoriasis.
Synonyms: related_synonym: 1-(3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea; 1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea; BIRB 796; N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea
alt_id: MESH:C452139
xref: CAS:285983-48-4
xref_mesh: MESH:C452139
xref: Reaxys:9170597; kegg.drug:D03736; lincs.smallmolecule:LSM-1170; pdb-ccd:B96; pubmed:11896401; pubmed:19244237; pubmed:20655210; pubmed:23685672; pubmed:25358442; pubmed:25589935; pubmed:26044359; pubmed:26232862
chemrof_formula: C31H37N5O3
chemrof_smiles: Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1
chemrof_inchi: InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)
chemrof_inchikey: MVCOAUNKQVWQHZ-UHFFFAOYSA-N
G
Abcc2
ATP binding cassette subfamily C member 2
increases expression
ISO
doramapimod results in increased expression of ABCC2 mRNA
CTD
PMID:21328587
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
G
Actg2
actin gamma 2, smooth muscle
increases expression
EXP
doramapimod results in increased expression of ACTG2 mRNA
CTD
PMID:24303162
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:117,579,514...117,604,295
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
EXP
doramapimod results in increased expression of ADH7 mRNA
CTD
PMID:24303162
NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:229,421,252...229,436,691
G
Ahsg
alpha-2-HS-glycoprotein
decreases expression
ISO
doramapimod results in decreased expression of AHSG mRNA
CTD
PMID:21328587
NCBI chr11:91,625,975...91,632,583
Ensembl chr11:91,625,975...91,634,039
G
Ak5
adenylate kinase 5
increases expression
EXP
doramapimod results in increased expression of AK5 mRNA
CTD
PMID:24303162
NCBI chr 2:244,057,240...244,241,372
Ensembl chr 2:244,057,240...244,241,366
G
Akr1b7
aldo-keto reductase family 1, member B7
increases expression
ISO
doramapimod results in increased expression of AKR1B7 mRNA
CTD
PMID:21328587
NCBI chr 4:64,043,901...64,083,751
Ensembl chr 4:64,020,686...64,064,909
G
Apoa4
apolipoprotein A4
decreases expression
ISO
doramapimod results in decreased expression of APOA4 mRNA
CTD
PMID:21328587
NCBI chr 8:55,435,779...55,438,160
Ensembl chr 8:55,434,168...55,438,164
G
C1qa
complement C1q A chain
decreases expression
ISO
doramapimod results in decreased expression of C1QA mRNA
CTD
PMID:21328587
NCBI chr 5:154,417,086...154,419,933
Ensembl chr 5:154,417,087...154,427,732
G
C1qb
complement C1q B chain
decreases expression
ISO
doramapimod results in decreased expression of C1QB mRNA
CTD
PMID:21328587
NCBI chr 5:154,402,276...154,407,827
Ensembl chr 5:154,402,279...154,407,840
G
Ca3
carbonic anhydrase 3
decreases expression
ISO
doramapimod results in decreased expression of CAR3 mRNA
CTD
PMID:21328587
NCBI chr 2:88,491,666...88,501,299
Ensembl chr 2:88,491,670...88,500,524
G
Casp3
caspase 3
multiple interactions
ISO
doramapimod promotes the reaction [TNF protein results in increased activity of CASP3 protein]
CTD
PMID:28629242
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Cd5l
Cd5 molecule-like
decreases expression
ISO
doramapimod results in decreased expression of CD5L mRNA
CTD
PMID:21328587
NCBI chr 2:175,088,915...175,099,928
Ensembl chr 2:175,088,884...175,099,926
G
Cd74
CD74 molecule
decreases expression
ISO
doramapimod results in decreased expression of CD74 mRNA
CTD
PMID:21328587
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
G
Ceacam1
CEA cell adhesion molecule 1
decreases expression
EXP
doramapimod results in decreased expression of CEACAM1 mRNA
CTD
PMID:24303162
NCBI chr 1:90,171,401...90,187,810
Ensembl chr 1:90,171,401...90,187,798
G
Ces3a
carboxylesterase 3a
increases expression
ISO
doramapimod results in increased expression of CES3 mRNA
CTD
PMID:21328587
NCBI chr19:49,902,312...49,910,484
G
Clec1b
C-type lectin domain family 1, member B
decreases expression
ISO
doramapimod results in decreased expression of CLEC1B mRNA
CTD
PMID:21328587
NCBI chr 4:164,533,987...164,542,320
Ensembl chr 4:164,534,055...164,542,867
G
Ctss
cathepsin S
decreases expression
ISO
doramapimod results in decreased expression of CTSS mRNA
CTD
PMID:21328587
NCBI chr 2:185,775,316...185,803,440
Ensembl chr 2:185,775,296...185,803,440
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]
CTD
PMID:14997032
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
G
Cxcl10
C-X-C motif chemokine ligand 10
decreases secretion
ISO
doramapimod results in decreased secretion of CXCL10 protein
CTD
PMID:17996064
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 protein]
CTD
PMID:14997032
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624
G
Cxcr1
C-X-C motif chemokine receptor 1
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in decreased expression of CXCR1 protein]
CTD
PMID:14997032
NCBI chr 9:83,216,040...83,220,225
Ensembl chr 9:83,215,292...83,226,872
G
Cxcr2
C-X-C motif chemokine receptor 2
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in decreased expression of CXCR2 protein]
CTD
PMID:14997032
NCBI chr 9:83,178,645...83,185,017
Ensembl chr 9:83,183,808...83,188,602
G
Cyp2a3
cytochrome P450, family 2, subfamily a, polypeptide 3
increases expression
ISO
doramapimod results in increased expression of CYP2A4 mRNA
CTD
PMID:21328587
NCBI chr 1:91,299,584...91,307,650
Ensembl chr 1:91,299,561...91,307,649
G
Cyss
cystatin S
decreases expression
EXP
doramapimod results in decreased expression of CYSS mRNA
CTD
PMID:24303162
NCBI chr 3:157,892,660...157,897,265
Ensembl chr 3:157,892,660...157,897,265
G
Egr1
early growth response 1
increases expression
ISO
doramapimod results in increased expression of EGR1 mRNA
CTD
PMID:21328587
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,736,838...26,740,843
G
Fcgr2b
Fc gamma receptor 2B
decreases expression
ISO
doramapimod results in decreased expression of FCGR2B mRNA
CTD
PMID:21328587
NCBI chr13:85,725,897...85,740,517
Ensembl chr13:85,725,897...85,740,517
G
Fgf8
fibroblast growth factor 8
decreases expression
EXP
doramapimod results in decreased expression of FGF8 mRNA
CTD
PMID:24303162
NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:254,533,504...254,539,605
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression
ISO
doramapimod results in decreased expression of G6PC1 mRNA
CTD
PMID:21328587
NCBI chr10:86,807,659...86,819,023
Ensembl chr10:86,757,899...86,818,033
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
doramapimod results in increased expression of GCLC mRNA
CTD
PMID:21328587
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
G
Gpx2
glutathione peroxidase 2
increases expression
ISO
doramapimod results in increased expression of GPX2 mRNA
CTD
PMID:21328587
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
G
Grm8
glutamate metabotropic receptor 8
increases expression
EXP
doramapimod results in increased expression of GRM8 mRNA
CTD
PMID:24303162
NCBI chr 4:56,771,247...57,696,951
Ensembl chr 4:56,770,771...57,687,639
G
Gsta2
glutathione S-transferase alpha 2
increases expression
ISO
doramapimod results in increased expression of GSTA1 mRNA
CTD
PMID:21328587
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:88,064,616...88,077,092
G
Gstm2
glutathione S-transferase mu 2
increases expression
ISO
doramapimod results in increased expression of GSTM2 mRNA
CTD
PMID:21328587
NCBI chr 2:198,312,179...198,316,962
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
doramapimod results in increased expression of GSTM3 mRNA
CTD
PMID:21328587
NCBI chr 2:198,219,769...198,222,732
Ensembl chr 2:198,219,647...198,222,731
G
Hp
haptoglobin
decreases expression
ISO
doramapimod results in decreased expression of HP mRNA
CTD
PMID:21328587
NCBI chr19:54,449,151...54,453,701
Ensembl chr19:54,446,217...54,467,518
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
decreases expression
EXP
doramapimod results in decreased expression of HPD mRNA
CTD
PMID:24303162
NCBI chr12:39,042,246...39,053,596
Ensembl chr12:39,042,238...39,053,612
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
doramapimod inhibits the reaction [Dinitrofluorobenzene results in increased expression of ICAM1 protein]
CTD
PMID:19427879
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
G
Il1b
interleukin 1 beta
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
CTD
PMID:28629242
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
G
Kcnk1
potassium two pore domain channel subfamily K member 1
decreases expression
EXP
doramapimod results in decreased expression of KCNK1 mRNA
CTD
PMID:24303162
NCBI chr19:70,856,985...70,895,053
Ensembl chr19:70,856,985...70,895,051
G
Lmod1
leiomodin 1
increases expression
EXP
doramapimod results in increased expression of LMOD1 mRNA
CTD
PMID:24303162
NCBI chr13:49,305,693...49,347,970
Ensembl chr13:49,305,830...49,348,116
G
Mapk14
mitogen activated protein kinase 14
decreases activity
ISO
doramapimod results in decreased activity of MAPK14 protein
CTD
PMID:28629242
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
G
Meig1
meiosis/spermiogenesis associated 1
increases expression
ISO
doramapimod results in increased expression of MEIG1 mRNA
CTD
PMID:21328587
NCBI chr17:79,718,630...79,737,604
Ensembl chr17:79,723,811...79,737,533
G
Mt1a
metallothionein 1A
increases expression
ISO
doramapimod results in increased expression of MT1 mRNA
CTD
PMID:21328587
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
G
Mybpc1
myosin binding protein C1
decreases expression
EXP
doramapimod results in decreased expression of MYBPC1 mRNA
CTD
PMID:24303162
NCBI chr 7:24,817,770...24,903,681
Ensembl chr 7:24,817,561...24,903,544
G
Myh11
myosin heavy chain 11
increases expression
EXP
doramapimod results in increased expression of MYH11 mRNA
CTD
PMID:24303162
NCBI chr10:1,250,554...1,345,681
Ensembl chr10:1,263,194...1,345,678
G
Myh3
myosin heavy chain 3
increases expression
EXP
doramapimod results in increased expression of MYH3 mRNA
CTD
PMID:24303162
NCBI chr10:52,269,185...52,293,000
Ensembl chr10:52,269,185...52,293,000
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
doramapimod results in increased expression of NQO1 mRNA
CTD
PMID:21328587
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
G
Olr59
olfactory receptor 59
increases expression
EXP
doramapimod results in increased expression of OLR59 mRNA
CTD
PMID:24303162
NCBI chr 1:166,604,972...166,639,634
Ensembl chr 1:166,604,141...166,623,265
G
Otog
otogelin
decreases expression
EXP
doramapimod results in decreased expression of OTOG mRNA
CTD
PMID:24303162
NCBI chr 1:105,882,747...105,951,825
Ensembl chr 1:105,882,747...105,951,824
G
Pfn2
profilin 2
increases expression
ISO
doramapimod results in increased expression of PFN2 mRNA
CTD
PMID:21328587
NCBI chr 2:144,217,100...144,222,936
Ensembl chr 2:144,205,636...144,222,936
G
Pon1
paraoxonase 1
decreases expression
EXP
doramapimod results in decreased expression of PON1 mRNA
CTD
PMID:24303162
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:34,261,289...34,287,924
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
doramapimod results in increased expression of PPARG mRNA
CTD
PMID:21328587
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
G
Prm2
protamine 2
increases expression
ISO
doramapimod results in increased expression of PRM2 mRNA
CTD
PMID:21328587
NCBI chr10:5,383,208...5,383,949
Ensembl chr10:5,379,029...5,384,004
G
Rgs4
regulator of G-protein signaling 4
increases expression
EXP
doramapimod results in increased expression of RGS4 mRNA
CTD
PMID:24303162
NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884
G
RT1-Bb
RT1 class II, locus Bb
decreases expression
ISO
doramapimod results in decreased expression of H2-AB1 mRNA
CTD
PMID:21328587
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
doramapimod results in increased expression of SLC7A11 mRNA
CTD
PMID:21328587
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
G
Spock2
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 2
decreases expression
EXP
doramapimod results in decreased expression of SPOCK2 mRNA
CTD
PMID:24303162
NCBI chr20:28,580,262...28,607,198
Ensembl chr20:28,580,226...28,608,409
G
Spsb1
splA/ryanodine receptor domain and SOCS box containing 1
decreases expression
ISO
doramapimod results in decreased expression of SPSB1 mRNA
CTD
PMID:21328587
NCBI chr 5:165,641,255...165,701,482
Ensembl chr 5:165,642,851...165,654,225
G
Srxn1
sulfiredoxin 1
increases expression
ISO
doramapimod results in increased expression of SRXN1 mRNA
CTD
PMID:21328587
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
G
Stmn2
stathmin 2
increases expression
EXP
doramapimod results in increased expression of STMN2 mRNA
CTD
PMID:24303162
NCBI chr 2:95,112,017...95,159,642
Ensembl chr 2:95,112,019...95,159,335
G
Tnf
tumor necrosis factor
multiple interactions
ISO
doramapimod inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; doramapimod promotes the reaction [TNF protein results in increased activity of CASP3 protein] doramapimod inhibits the reaction [nivalenol results in increased secretion of TNF protein]
CTD
PMID:28629242 PMID:38616237
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Vsig4
V-set and immunoglobulin domain containing 4
decreases expression
ISO
doramapimod results in decreased expression of VSIG4 mRNA
CTD
PMID:21328587
NCBI chr X:65,154,422...65,179,708
Ensembl chr X:65,154,424...65,179,708
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all